CN102666568A - 纯化多肽的方法 - Google Patents
纯化多肽的方法 Download PDFInfo
- Publication number
- CN102666568A CN102666568A CN201080057393XA CN201080057393A CN102666568A CN 102666568 A CN102666568 A CN 102666568A CN 201080057393X A CN201080057393X A CN 201080057393XA CN 201080057393 A CN201080057393 A CN 201080057393A CN 102666568 A CN102666568 A CN 102666568A
- Authority
- CN
- China
- Prior art keywords
- compound
- ion exchange
- exchange matrix
- desired polypeptides
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
Abstract
Description
实验(装载液中的EDTA浓度) | 聚集物 | 单体 | 片段 |
对照1 | 6.91 | 83.63 | 9.46 |
对照2 | 6.23 | 87.47 | 6.3 |
对照3 | 9.89 | 85.0 | 5.11 |
10mM EDTA | 3.84 | 92.2 | 3.95 |
20mM EDTA | 3.79 | 93.16 | 3.04 |
33mM EDTA | 3.66 | 93.6 | 2.75 |
35mM EDTA | 3.52 | 94.43 | 2.5 |
36mM EDTA | 1.75 | 92.46 | 5.79 |
50mM EDTA | 2.33 | 94.89 | 2.78 |
Claims (29)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09015707 | 2009-12-18 | ||
EP09015707.4 | 2009-12-18 | ||
PCT/EP2010/069713 WO2011073235A1 (en) | 2009-12-18 | 2010-12-15 | Method of purifying polypeptides |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410391341.6A Division CN104193798A (zh) | 2009-12-18 | 2010-12-15 | 纯化多肽的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102666568A true CN102666568A (zh) | 2012-09-12 |
CN102666568B CN102666568B (zh) | 2015-12-09 |
Family
ID=42229094
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410391341.6A Pending CN104193798A (zh) | 2009-12-18 | 2010-12-15 | 纯化多肽的方法 |
CN201080057393.XA Active CN102666568B (zh) | 2009-12-18 | 2010-12-15 | 纯化多肽的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410391341.6A Pending CN104193798A (zh) | 2009-12-18 | 2010-12-15 | 纯化多肽的方法 |
Country Status (12)
Country | Link |
---|---|
US (3) | US20140080200A1 (zh) |
EP (3) | EP2513135B1 (zh) |
JP (1) | JP5984676B2 (zh) |
KR (1) | KR20120108989A (zh) |
CN (2) | CN104193798A (zh) |
AU (1) | AU2010332959B2 (zh) |
CA (1) | CA2783207A1 (zh) |
DK (1) | DK2513135T3 (zh) |
ES (1) | ES2796829T3 (zh) |
PL (1) | PL3715356T3 (zh) |
SG (2) | SG10201407983VA (zh) |
WO (1) | WO2011073235A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533940A (zh) * | 2018-03-21 | 2021-03-19 | 百深公司 | 通过色谱方法分离vwf和vwf前肽 |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104193798A (zh) | 2009-12-18 | 2014-12-10 | Csl有限公司 | 纯化多肽的方法 |
PT2563805T (pt) | 2010-04-29 | 2020-05-18 | Baxalta Inc | Método de purificação de proteínas que se ligam a catiões divalentes em resina de permuta aniónica |
WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
PL2748179T3 (pl) | 2011-10-14 | 2022-04-11 | Takeda Pharmaceutical Company Limited | Oczyszczanie białka metodą anionowej chromatografii jonowymiennej |
WO2013053888A1 (en) | 2011-10-14 | 2013-04-18 | Baxter International Inc. | Protein purification by anion exchange chromatography |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
CA2883272A1 (en) | 2012-09-02 | 2014-03-06 | Abbvie Inc. | Methods to control protein heterogeneity |
CA2905010A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
DK2970376T3 (en) | 2013-03-15 | 2018-07-02 | Baxalta Inc | PURIFICATION PROCEDURE FOR VITAMIN K-DEPENDENT PROTEINS BY ANION EXCHANGE CHROMATOGRAPHY |
WO2015051293A2 (en) | 2013-10-04 | 2015-04-09 | Abbvie, Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
WO2017127567A1 (en) * | 2016-01-19 | 2017-07-27 | Genebiologics, Llc | Production of arginine-rich proteins and use as a fertilizer and germination enhancer |
EP4070102A1 (en) | 2019-12-05 | 2022-10-12 | Waters Technologies Corporation | Polyphosphonic acids for improving recovery and minimizing system loss |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055203A1 (en) * | 1999-03-15 | 2000-09-21 | Novo Nordisk A/S | Ion exchange chromatographic separation of glp-1 and related peptides |
CN101031644A (zh) * | 2004-09-29 | 2007-09-05 | 诺和诺德医疗保健公司 | 通过分级洗脱从阴离子交换材料中纯化批量凝血因子ⅶ多肽 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US499437A (en) | 1893-06-13 | Ditching-scoop | ||
WO1984000560A1 (en) | 1982-08-04 | 1984-02-16 | Nat Res Dev | Molecular cloning of the gene for human anti-haemophilic factor ix |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
JPS63501471A (ja) | 1984-12-27 | 1988-06-09 | サントリー株式会社 | インタ−フェロンの精製方法 |
GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4994371A (en) | 1987-08-28 | 1991-02-19 | Davie Earl W | DNA preparation of Christmas factor and use of DNA sequences |
US5061815A (en) * | 1988-07-06 | 1991-10-29 | Zinpro Corporation | Metal lysine complexes and method for producing metal lysine complexes |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
US5641887A (en) * | 1994-04-01 | 1997-06-24 | University Of Pittsburgh | Extraction of metals in carbon dioxide and chelating agents therefor |
US5968772A (en) * | 1995-05-09 | 1999-10-19 | Matsushiro; Aizo | Pearl protein (nacrein) and process for producing the same |
US6268487B1 (en) * | 1996-05-13 | 2001-07-31 | Genzyme Transgenics Corporation | Purification of biologically active peptides from milk |
KR100554332B1 (ko) | 1996-11-15 | 2006-02-24 | 제넨테크, 인크. | 뉴로트로핀의 정제 |
US20030036629A1 (en) | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
US7544500B2 (en) * | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
SE9904237D0 (sv) * | 1999-11-22 | 1999-11-22 | Ana Mar Diagnostics Ab | New compound |
SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
CA2466054C (en) | 2001-11-13 | 2012-01-03 | Genentech, Inc. | Apo-2 ligand/trail formulations |
US7741285B2 (en) | 2001-11-13 | 2010-06-22 | Genentech, Inc. | APO-2 ligand/trail formulations |
PT1501369E (pt) | 2002-04-26 | 2015-09-21 | Genentech Inc | Purificação de proteínas com base na não afinidade |
WO2004006962A2 (en) * | 2002-07-12 | 2004-01-22 | Novo Nordisk A/S | A tissue factor binding immunoconjugate comprising factor viia |
US20040048315A1 (en) * | 2002-08-28 | 2004-03-11 | Pharmacia Corporation | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
DE60228460D1 (de) * | 2002-12-13 | 2008-10-02 | Bioceuticals Arzneimittel Ag | Verfahren zur Herstellung und Reinigung von Erythropoietin |
PL1831242T3 (pl) * | 2004-12-23 | 2013-04-30 | Novo Nordisk Healthcare Ag | Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania |
CA2604877A1 (en) | 2005-04-11 | 2006-10-19 | J.P. Sercel Associates Inc. | Protein purification |
JP2009508476A (ja) * | 2005-08-31 | 2009-03-05 | セントカー・インコーポレーテツド | 高められたエフェクター機能をもつ抗体定常領域の製造用の宿主細胞株 |
EP1924688A1 (en) * | 2005-09-01 | 2008-05-28 | Novo Nordisk Health Care AG | Purification of coagulation factor vii polypeptides |
JP5401097B2 (ja) | 2005-12-23 | 2014-01-29 | ノボ・ノルデイスク・エー/エス | 分取逆相クロマトグラフィー(rpc)を使用するタンパク質精製 |
CA2645739A1 (en) | 2006-03-20 | 2007-09-27 | Medarex, Inc. | Protein purification |
EP3088410A3 (en) | 2006-04-05 | 2016-12-28 | AbbVie Biotechnology Ltd | Antibody purification |
JP5800458B2 (ja) | 2006-06-14 | 2015-10-28 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 血液凝固因子を有するタンパク質分解によって切断可能な融合タンパク質 |
JP5374840B2 (ja) * | 2006-07-20 | 2013-12-25 | Jnc株式会社 | カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途 |
CL2007002615A1 (es) | 2006-09-08 | 2008-04-18 | Wyeth Corp | Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto. |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
CA2673851C (en) | 2007-01-22 | 2016-05-03 | Genentech, Inc. | Polyelectrolyte precipitation and purification of proteins |
US8399632B2 (en) * | 2007-02-28 | 2013-03-19 | Baxter International Inc. | Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules |
WO2008122089A1 (en) | 2007-04-05 | 2008-10-16 | The University Of Queensland | Method of purifying recombinant peptides by selective precipitation |
TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至her2結構域ii之抗體及其酸性變異體的組合物 |
CA2726823A1 (en) | 2008-06-03 | 2009-12-10 | Patrys Limited | Process for purification of antibodies |
WO2010063717A1 (en) * | 2008-12-02 | 2010-06-10 | Novo Nordisk A/S | Polypeptide purification |
WO2011018515A1 (en) * | 2009-08-14 | 2011-02-17 | Novo Nordisk Health Care Ag | Method of purifying pegylated proteins |
CN104193798A (zh) | 2009-12-18 | 2014-12-10 | Csl有限公司 | 纯化多肽的方法 |
-
2010
- 2010-12-15 CN CN201410391341.6A patent/CN104193798A/zh active Pending
- 2010-12-15 CA CA2783207A patent/CA2783207A1/en not_active Abandoned
- 2010-12-15 WO PCT/EP2010/069713 patent/WO2011073235A1/en active Application Filing
- 2010-12-15 ES ES10798291T patent/ES2796829T3/es active Active
- 2010-12-15 US US13/516,740 patent/US20140080200A1/en not_active Abandoned
- 2010-12-15 SG SG10201407983VA patent/SG10201407983VA/en unknown
- 2010-12-15 SG SG2012040879A patent/SG181496A1/en unknown
- 2010-12-15 KR KR1020127018780A patent/KR20120108989A/ko not_active Application Discontinuation
- 2010-12-15 CN CN201080057393.XA patent/CN102666568B/zh active Active
- 2010-12-15 DK DK10798291.0T patent/DK2513135T3/da active
- 2010-12-15 EP EP10798291.0A patent/EP2513135B1/en active Active
- 2010-12-15 EP EP23202384.6A patent/EP4328305A2/en active Pending
- 2010-12-15 EP EP20162007.7A patent/EP3715356B1/en active Active
- 2010-12-15 JP JP2012543705A patent/JP5984676B2/ja not_active Expired - Fee Related
- 2010-12-15 AU AU2010332959A patent/AU2010332959B2/en not_active Ceased
- 2010-12-15 PL PL20162007.7T patent/PL3715356T3/pl unknown
-
2015
- 2015-07-30 US US14/813,461 patent/US20160185816A1/en not_active Abandoned
-
2019
- 2019-06-28 US US16/455,856 patent/US20190330267A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055203A1 (en) * | 1999-03-15 | 2000-09-21 | Novo Nordisk A/S | Ion exchange chromatographic separation of glp-1 and related peptides |
CN101031644A (zh) * | 2004-09-29 | 2007-09-05 | 诺和诺德医疗保健公司 | 通过分级洗脱从阴离子交换材料中纯化批量凝血因子ⅶ多肽 |
Non-Patent Citations (1)
Title |
---|
GAGNON P等: "Method for obtaining unique selectivities in ion-exchange chromatography by addition of organic polymers to the mobile phase", 《JOURNAL OF CHROMATOGRAPHY A》, vol. 743, 31 December 1996 (1996-12-31), pages 51 - 55, XP004020270, DOI: doi:10.1016/0021-9673(96)00125-2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533940A (zh) * | 2018-03-21 | 2021-03-19 | 百深公司 | 通过色谱方法分离vwf和vwf前肽 |
Also Published As
Publication number | Publication date |
---|---|
US20190330267A1 (en) | 2019-10-31 |
CN104193798A (zh) | 2014-12-10 |
EP3715356A1 (en) | 2020-09-30 |
AU2010332959A1 (en) | 2012-07-05 |
WO2011073235A1 (en) | 2011-06-23 |
SG181496A1 (en) | 2012-07-30 |
EP4328305A2 (en) | 2024-02-28 |
SG10201407983VA (en) | 2015-01-29 |
PL3715356T3 (pl) | 2024-03-11 |
CN102666568B (zh) | 2015-12-09 |
US20140080200A1 (en) | 2014-03-20 |
JP2013514310A (ja) | 2013-04-25 |
DK2513135T3 (da) | 2020-05-18 |
EP2513135B1 (en) | 2020-04-22 |
EP3715356B1 (en) | 2023-10-11 |
EP3715356C0 (en) | 2023-10-11 |
JP5984676B2 (ja) | 2016-09-06 |
AU2010332959B2 (en) | 2015-08-06 |
CA2783207A1 (en) | 2011-06-23 |
KR20120108989A (ko) | 2012-10-05 |
EP2513135A1 (en) | 2012-10-24 |
ES2796829T3 (es) | 2020-11-30 |
US20160185816A1 (en) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102666568A (zh) | 纯化多肽的方法 | |
JP7142021B2 (ja) | 糖タンパク質製造プロセス | |
CN104023804A (zh) | 超载和洗脱层析 | |
CN103814044A (zh) | 纯化fc-融合蛋白的方法 | |
US11913039B2 (en) | Method for producing recombinant alkaline phosphatase | |
JP2016538267A (ja) | 抗体精製 | |
CA3066893A1 (en) | Cation exchange chromatography wash buffer | |
AU2019203712B2 (en) | Method of purifying polypeptides | |
JP2023546682A (ja) | アルカリホスファターゼの製造中に総シアル酸含量(tsac)を制御する方法 | |
WO2023167847A2 (en) | Bioreactor for antibody production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: A.Charlton Inventor after: M.Napoli Inventor after: P.Smulderji Inventor after: A.Storrs Inventor after: V.Pilzas Inventor after: M.Schroeder Inventor after: I.Walker Inventor before: A.Charlton Inventor before: M.Napoli Inventor before: P.Smulderji Inventor before: A.Storrs Inventor before: V.Pilzas Inventor before: M.Schroeder |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHARLTON ADAM NAPOLI MARK SMRDELJ PAUL STOWERS ANTHONY PIRZAS VICKY SCHROEDER MAGNUS TO: CHARLTON ADAM NAPOLI MARK SMRDELJ PAUL STOWERS ANTHONY PIRZAS VICKY SCHROEDER MAGNUS WALKER IAN |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Vitoria Australia Applicant after: Ztel company limited Address before: Vitoria Australia Applicant before: CSL Limited |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: CSL LIMITED TO: JETT LTD. Free format text: CORRECT: ADDRESS; FROM: |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |